75
Growth Score
pts
Heat Score
74 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4649165
Akigai AS develops pharmaceutical treatments targeting neuropathic pain and complex regional pain syndrome using repurposed drugs.
About the Company
Akigai AS develops pharmaceutical treatments for neuropathic pain conditions with a focus on complex regional pain syndrome (CRPS). The company holds a global use patent for repurposed drugs that have an established safety profile in other indications. It conducts biotech research and clinical studies to demonstrate efficacy in severe pain
disorders where no approved therapies exist. Akigai AS collaborates with clinical researchers and aims to bring regulatory-approved options to patients with debilitating pain. Its medicines are under development and are not yet approved or reimbursed.
